Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial


YILDIZ B. P. , BAYRAKTAROĞLU M., GÖRGÜN D., YÜKSEL K.

Clinical Drug Investigation, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier